CY1111521T1 - Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων - Google Patents

Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων

Info

Publication number
CY1111521T1
CY1111521T1 CY20111100163T CY111100163T CY1111521T1 CY 1111521 T1 CY1111521 T1 CY 1111521T1 CY 20111100163 T CY20111100163 T CY 20111100163T CY 111100163 T CY111100163 T CY 111100163T CY 1111521 T1 CY1111521 T1 CY 1111521T1
Authority
CY
Cyprus
Prior art keywords
calculous
calculus
fcv
double system
present
Prior art date
Application number
CY20111100163T
Other languages
English (en)
Inventor
Janet E Foley
Kate Hurley
Niels C Pedersen
Amy Poland
Original Assignee
Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04720404A external-priority patent/EP1606391B1/en
Application filed by Regents Of The University Of California filed Critical Regents Of The University Of California
Publication of CY1111521T1 publication Critical patent/CY1111521T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε ένα εμβόλιο για την ανοσοποίηση κατά μίας ιικής μολύνσεως προκαλούμενης από λοιμογόνο συστηματικό καλυκοϊό των αιλουροειδών (VS-FCV), μία νέα, άτυπη και ασυνήθιστα λοιμογόνο μορφή καλυκοϊού που καταλήγει σε ιδιαιτέρως μεταδοτικό και θανατηφόρο σύνδρομο αιμορραγικού πυρετού. Η παρούσα εφεύρεση περικλείει επιπλέον μεθόδους ανοσοποιήσεως των γατών έναντι συγκεκριμένων στελεχών του VS-FCV.
CY20111100163T 2003-03-14 2011-02-11 Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων CY1111521T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/388,837 US7309495B2 (en) 2003-03-14 2003-03-14 Hemorrhagic feline calicivirus
US10/769,531 US7264816B2 (en) 2003-03-14 2004-01-30 Virulent systemic feline calicivirus
EP04720404A EP1606391B1 (en) 2003-03-14 2004-03-12 Virulent systemic feline calicivirus

Publications (1)

Publication Number Publication Date
CY1111521T1 true CY1111521T1 (el) 2014-02-12

Family

ID=32962139

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100163T CY1111521T1 (el) 2003-03-14 2011-02-11 Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων

Country Status (10)

Country Link
US (3) US7309495B2 (el)
EP (1) EP2301574A1 (el)
JP (1) JP4724112B2 (el)
AT (1) ATE495758T1 (el)
CY (1) CY1111521T1 (el)
DE (1) DE602004031092D1 (el)
DK (1) DK1606391T3 (el)
ES (1) ES2358798T3 (el)
NZ (1) NZ541449A (el)
PT (1) PT1606391E (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same
AU2008260593A1 (en) * 2007-05-30 2008-12-11 Wyeth Raccoon poxvirus expressing genes of feline antigens
EP3389706A1 (en) 2015-12-14 2018-10-24 Boehringer Ingelheim Vetmedica, Inc. Hybrid core feline vaccines
RU2628096C1 (ru) * 2016-06-01 2017-08-14 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Штамм Эшли вируса калицивироза кошек для изучения противовирусной активности препаратов в отношении калицивироза кошек
CA3080430A1 (en) 2017-11-06 2019-06-13 Intervet International B.V. Feline calicivirus vaccine
US11167027B2 (en) 2017-11-06 2021-11-09 Intervet Inc. Multivalent feline vaccine
JP7374893B2 (ja) 2017-12-08 2023-11-07 インターベット インターナショナル ベー． フェー． ネコカリシウイルスワクチン
JP7427585B2 (ja) 2017-12-15 2024-02-05 インターベット インターナショナル ベー． フェー． 多価ネコワクチン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937812A (en) 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3944469A (en) 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3992520A (en) 1974-11-27 1976-11-16 Merck & Co., Inc. Anti-fertility vaccine comprising solubilized zona pellucida and anti-serum
US4522810A (en) * 1982-12-09 1985-06-11 The Regents Of The University Of California Feline calicivirus vaccine
US4795634A (en) 1986-03-14 1989-01-03 Aphton Corporation Method for contraception by immunization against the zona pellucida
US5641487A (en) 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US5716822A (en) 1989-07-21 1998-02-10 Pharmacia & Upjohn Company Feline calicivirus capsid gene and protein
CA2090515C (en) 1992-02-28 2002-10-29 Kazuhiko Kimachi Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
JPH07503142A (ja) 1992-11-09 1995-04-06 ゾナジェン　インコーポレイテッド 免疫避妊剤及び方法
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US6355246B1 (en) 1999-06-10 2002-03-12 Board Of Trustees Of Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof

Also Published As

Publication number Publication date
US20040180064A1 (en) 2004-09-16
US20040259225A1 (en) 2004-12-23
ES2358798T3 (es) 2011-05-13
JP2006524503A (ja) 2006-11-02
ATE495758T1 (de) 2011-02-15
PT1606391E (pt) 2011-04-01
US7264816B2 (en) 2007-09-04
US20080063663A1 (en) 2008-03-13
US7309495B2 (en) 2007-12-18
DK1606391T3 (da) 2011-03-21
NZ541449A (en) 2009-01-31
JP4724112B2 (ja) 2011-07-13
EP2301574A1 (en) 2011-03-30
DE602004031092D1 (de) 2011-03-03
US7449323B2 (en) 2008-11-11

Similar Documents

Publication Publication Date Title
CY1111521T1 (el) Λοιμογονος συστηματικος καλυκοϊος αιλουροειδων
ATE542829T1 (de) Impfstoff
CY1112901T1 (el) Αιμορραγικος καλυκοϊος αιλουροειδων, εμβολιο καλυκοϊου και μεθοδος για προληψη μολυνσης και ασθενειας απο καλυκοϊο
CY1120015T1 (el) Μεθοδοι χορηγησης εμβολιων
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1111552T1 (el) Χρηση hpv16 και hpv18 ως εμβολιο εναντι ενος ή περισσοτερων ογκογονικου hpv τυπου 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
CY1106310T1 (el) Καθορισμος hbv αντιγονων για χρηση σε εμβολια
CY1113826T1 (el) Ανοσοενισχυτικα για εμβολια
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
CY1113546T1 (el) Μικρορευστοποιημενα γαλακτωματα ελαιου σε νερο και συνθεσεις εμβολιων
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
ATE485056T1 (de) Verbesserte impfstoffe
DK1881845T3 (da) Nipah-virusvacciner
CY1113540T1 (el) Εμβολια γριππης σκυλων
AR047581A1 (es) Vacunas de calicivirus felino
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
DE60115051D1 (de) Immunologische adjuvans verbindungen
ATE372129T1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
DK1657248T3 (da) Vaccine til forebyggelse og behandling af svine-progressiv atrofisk rhinitis
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).